Potential implications on female fertility and reproductive lifespan in BRCA germline mutation women
ConclusionsBRCAm women should not delay pregnancy, especially if they are BRCA1, older than 35 years or with previous gonadotoxic treatments. Future prospective studies on infertility outcomes in this population are needed.
Source: Archives of Gynecology and Obstetrics - Category: OBGYN Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Genetics | Hormones | Infertility | Men | Menopause | OBGYN | Ovarian Cancer | Ovaries | Pregnancy | Reproduction Medicine | Study | Tamoxifen | Women